SELECT YOUR REGION United States Products FlowTriever System ClotTriever System Protrieve InThrill System RevCore FlowStasis FlowSaver Clinical Research FLAME FLARE FLASH CLOUT PEERLESS DEFIANCE External Research Patient Stories VTE Excellence VTE Excellence Resources Investors & Media Investor Relations In the News Clot Gallery Resources Grants Reimbursement Contact Careers 550 Patients in RCT: 1:1 Enrolling up to 700 patients total, including a non-randomized cohort of up to 150 patients with absolute contraindication to thrombolytics. Primary Endpoint Win Ratio composite at discharge (7d max): 1. All-cause mortality2. Intracranial hemorrhage3. ISTH major bleeding4. Clinical deterioration and/or bailout5. ICU admission and ICU LOS Follow Up Patients followed through 30-day visit Index Procedure > 24-hour Visit > Hospital Discharge > 30-day Visit